Examining Novel Fentalogs: Pharmacological Characteristics and Reversibility
检查新型 Fentalogs:药理学特征和可逆性
基本信息
- 批准号:9901497
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2021-09-30
- 项目状态:已结题
- 来源:
- 关键词:AffinityAgonistBindingBinding ProteinsBiological AssayCessation of lifeCharacteristicsClinicCollaborationsCommunitiesCyclic AMPDataDoseFentanylForensic MedicineGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGoalsGuidelinesHealthcareHydrocodoneIn VitroLaw EnforcementLightLiteratureMaintenance TherapyMediatingMorphineNaloxoneNamesNarcanOpioidOpioid AnalgesicsOpioid AntagonistOpioid ReceptorOpioid agonistOverdosePainPatientsPharmaceutical PreparationsPharmacologyPlayProductivityPropertyRadioactiveReportingResuscitationRoleSamplingSeizuresSpecialistStreet DrugsStructure-Activity RelationshipTestingTimeUnited StatesVehicle crashVentilatory DepressionWorkaddictionanalogautomobile accidentcostdelta opioid receptordesignin vitro Modelin vivoinsightkappa opioid receptorsmu opioid receptorsnovelopioid epidemicopioid mortalityopioid overdoseoverdose deathpreventpreventable deathprotein degradationreceptorreceptor functionscaffoldstandard care
项目摘要
Opioid analgesics, such as morphine and hydrocodone, are widely used for the treatment
of moderate to severe pain but are also widely misused and abused. Opioid-related
overdoses account for almost half of all drug overdose deaths in the United States and
cause more preventable deaths every year than car crashes. Fentanyl, a highly potent
mu opioid receptor (MOR) agonist, and its analogues (fentalogs) are increasingly found
in drug samples from search and seizure by law enforcement and are thought to
contribute to the drastic increase in opioid-induced overdose deaths since 2016. In fact,
the number of deaths and drug seizures involving fentalogs is likely an underestimate, as
the rapid rate at which new fentalogs are synthesized makes it difficult for law
enforcement and forensic specialists to keep up. As many of these compounds are novel
analogs, very little is known about their basic pharmacology in terms of receptor affinity
or activity at the opioid receptors. The objective of this proposal is to evaluate novel
fentalogs, many of which have been identified in illicit samples, in terms of binding affinity
and receptor function at the three classical opioid receptors: MOR, the delta opioid
receptor (DOR), and the kappa opioid receptor (KOR). This will be accomplished using
standard competitive radioactive ligand binding and G protein turnover assays. The ability
of a standard rescue therapy, naloxone (trade name Evzio or Narcan), to reverse the
agonist activity of the most potent and efficacious fentalogs will also be examined; real
time cAMP accumulation will be used to determine agonist function and reversal by
antagonists, such as naloxone. The overarching hypothesis is that many of these novel
fentalogs are more potent and efficacious than traditional opioid agonists and that
standard treatments for opioid overdose may be insufficient when fentalogs are involved.
Overall, this project will characterize the in vitro pharmacological properties of novel
fentalogs found in street drugs and has the potential to inform best practices for
preventing opioid overdose and related deaths.
阿片类镇痛药,例如吗啡和氢可酮,被广泛用于治疗
中度至重度疼痛,但也被广泛滥用和滥用。阿片类药物有关
过量占美国药物过量死亡的几乎一半
每年造成可预防的死亡,而不是汽车撞车。芬太尼,高度有效
MU阿片受体(MOR)激动剂及其类似物(Fenalyogs)越来越多地发现
在执法部门搜查和扣押中的毒品样本中,被认为是
自2016年以来,阿片类药物诱发的过量死亡的急剧增加。
涉及脾气病毒的死亡和毒品癫痫发作的数量可能是低估的,因为
合成新的疾病的快速速度使法律困难
执法和法医专家跟上。这些化合物中的许多都是新颖的
类似物,关于受体亲和力的基本药理学知之甚少
或在阿片受体上的活性。该提议的目的是评估小说
在具有约束力的亲和力方面
和受体功能在三个经典阿片类药物受体上:MOR,三角洲阿片类药物
受体(DOR)和Kappa阿片受体(Kor)。这将使用
标准的竞争放射性配体结合和G蛋白周转测定。能力
标准救援疗法Naloxone(商品名EVZIO或NARCAN),以扭转
还将检查最有效和有效的疾病的激动剂活动;真实的
时间训练营的积累将用于确定激动剂功能和逆转
拮抗剂,例如纳洛酮。总体假设是这些小说中的许多
与传统的阿片类药物激动剂相比
当涉及疾病时,阿片类药物过量的标准治疗可能不足。
总体而言,该项目将表征新颖的体外药理特性
在街头毒品中发现的疾病,并有可能为最佳实践提供信息
防止阿片类药物过量和相关死亡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessica Priya Anand其他文献
Jessica Priya Anand的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessica Priya Anand', 18)}}的其他基金
Development of Long Lasting Stable Fentanyl Antagonist to Reverse Opioid Overdose
开发长效稳定芬太尼拮抗剂以逆转阿片类药物过量
- 批准号:
10197869 - 财政年份:2020
- 资助金额:
$ 7.8万 - 项目类别:
Development of Long Lasting Stable Fentanyl Antagonist to Reverse Opioid Overdose
开发长效稳定芬太尼拮抗剂以逆转阿片类药物过量
- 批准号:
10041480 - 财政年份:2020
- 资助金额:
$ 7.8万 - 项目类别:
相似国自然基金
基于结构信息的非肽类GLP-1R激动剂结合口袋解析和药理机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于结构信息的非肽类GLP-1R激动剂结合口袋解析和药理机制研究
- 批准号:82273985
- 批准年份:2022
- 资助金额:52.00 万元
- 项目类别:面上项目
靶向EcR新型广谱蜕皮激动剂的设计、合成与活性研究
- 批准号:21907084
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
基于高效模拟设计的抗哮喘靶标蛋白TG2激动剂的发现优化
- 批准号:81872797
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
慢性肾脏病相关毒素调节酸敏感离子通道1a的功能和机制研究
- 批准号:31800853
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 7.8万 - 项目类别:
Decoding the functional pleiotropy of IL-20Rβ ligands in inflammation and tumorigenesis
解码 IL-20Rβ 配体在炎症和肿瘤发生中的功能多效性
- 批准号:
10350447 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
- 批准号:
10659658 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
- 批准号:
10608439 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别: